Altamira Therapeutics Ltd
CYTO
CYTO was delisted on the 19th of December, 2024.
8 hedge funds and large institutions have $217K invested in Altamira Therapeutics Ltd in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
359% more capital invested
Capital invested by funds: $47.3K → $217K (+$170K)
60% more funds holding
Funds holding: 5 → 8 (+3)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$294K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.61K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$3.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$12K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $203K | +$294K | +41,450 | New |
|
|
2
Citadel Advisors
Miami,
Florida
| $9.45K | -$12K | -1,689 | -46% |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $2.46K | +$3.61K | +509 | New |
|
|
XT
4
XTX Topco
George Town,
Cayman Islands
| $2.44K | +$3.6K | +507 | New |
|
5
Morgan Stanley
New York
| $122 | – | – | – |
|
6
Group One Trading
Chicago,
Illinois
| $72 | – | – | – |
|
7
Wells Fargo
San Francisco,
California
| $6 | – | – | – |
|
|
SCA
8
Stonebridge Capital Advisors
St Paul,
Minnesota
| $1 | – | – | – |
|
CYTO Hedge Fund Activity: Q3 2023 in Review
8 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Altamira Therapeutics Ltd (CYTO) for Q3 2023, worth a combined $217K — up 359% from $47.3K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CYTO positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $294K. The largest seller was Citadel Advisors, cutting an estimated $12K.
- 8 institutional investors held Altamira Therapeutics Ltd (CYTO) as of Q3 2023, up from 5 in Q2 2023.
- Funds reported $217K of Altamira Therapeutics Ltd stock for Q3 2023, up 359% quarter-over-quarter.
- 3 funds opened new Altamira Therapeutics Ltd positions in Q3 2023 and 0 closed out, a net change of +3 holders.
- The largest Altamira Therapeutics Ltd buyer in Q3 2023 was Armistice Capital, an estimated $294K added.
- The largest Altamira Therapeutics Ltd seller in Q3 2023 was Citadel Advisors, an estimated $12K sold.
Based on aggregated 13F filings for Q3 2023.